This is the kind of atmospheric chemistry plot twist that makes me want to call my old biochem professor. We won the ozone fight in the 1980s by banning CFCs and engineering replacements that looked friendlier on every spec sheet: shorter atmospheric lifetimes, lower greenhouse warming potential, less chlorine to chew on the stratosphere. Montreal Protocol, textbook win. Now here is the part the textbook left out. When those replacement molecules crack apart in the upper atmosphere, a chunk of them turn into trifluoroacetic acid (TFA), a small water-soluble forever chemical that does not biodegrade, washes out in the rain, and accumulates in living tissue. It is now the dominant PFAS in American blood. We did not put it there on purpose.

A new modeling study in Geophysical Research Letters from a Lancaster University team led by Lucy Hart put the global ledger on paper: roughly 335,500 tonnes of TFA rained down between 2000 and 2022, with annual deposition more than tripling across that window, from about 6,800 tonnes a year to 21,800. The model is validated against rainwater measurements and Arctic ice cores, and the team estimates production keeps climbing for decades, with the peak landing somewhere between 2025 and 2100. The uncertainty band itself tells you something. Nobody knows when this stops.

In Hart’s own framing, “CFC replacements are likely to be the dominant atmospheric source of TFA.” That covers the HCFCs and HFCs sitting in older air conditioners and refrigerators, the next-generation HFO-1234yf shipping in newer car AC systems, and the fluorinated inhalation anesthetic gases used in operating rooms worldwide. Your hospital, your fridge, and your commute are all contributing. Arctic ice cores show TFA piling up in places that have no local sources at all, which is what a globally distributed atmospheric forever chemical looks like in the wild.

The human exposure data is where this gets sharp. A peer-reviewed review in Environmental Science & Technology catalogued what is showing up in people, and the numbers do not flatter the low-toxicity, stay-calm framing. TFA alone makes up roughly 57% of the total PFAS mass measured in American blood serum, with a median around 6 μg/L and individual samples reaching 77 μg/L. The review’s own sentence: “concentrations of TFA in nonoccupationally exposed US citizens are similar to the concentrations of bioaccumulative legacy long-chain PFAAs measured in the serum of occupationally exposed workers.” In English: your blood now carries as much TFA as factory workers used to carry of the legacy PFAS that got banned. We have made the population an occupational cohort for a chemical nobody asked for.

The reassurance that current TFA levels sit below harm thresholds rests heavily on a regulatory record that has been quietly tightening. Germany’s Federal Environment Agency submitted evidence to the European Chemicals Agency proposing TFA be classified as a Category 1B “presumed human reproductive toxicant” based on embryo-fetal developmental toxicity in rabbits. Animal feeding studies have flagged liver hypertrophy in rats. The Netherlands has set a regulatory threshold of 2.2 μg/L, and some measured European drinking water supplies sit above that line. Agencies closest to the data are not behaving like they think the threshold is comfortable.

The structural pattern is what bothers me most. The Montreal Protocol got us off CFCs because chlorine was destroying stratospheric ozone, and the ozone hole started healing. The HFC generation that replaced CFCs turned out to be a serious greenhouse problem, so the Kigali Amendment phased those down too. The HFOs that came next were sold as the climate-friendly fix. At every transition the chemistry was optimized for one specific environmental endpoint, first ozone, then warming, and the breakdown chemistry got handed off to the next generation of regulators to worry about. TFA is the bill. As Lancaster’s Ryan Hossaini put it, “Although HFC use is gradually being phased down, this TFA source will remain with us for decades.”

The asymmetry of it would be funny if it were not in our bloodstreams. Industry got the speed of substitution it wanted at every transition. Agencies got to claim a regulatory victory at each step. The persistence cost gets paid by the next century’s rainwater, drinking water, and serum. If I were the EPA, I would want to know two things by yesterday: which specific HFO and HFC molecules yield the most TFA per kilogram released (the answer should be driving substitution rules right now), and which hospital anesthetic protocols can shift toward closed-circuit gas capture or alternative agents without hurting patient care. Those are the levers. The “current levels remain below harmful thresholds” line is the kind of soothing technocratic phrase that, by the time it stops being true, will have stopped being recoverable. TFA does not go away. We only get to decide how much more we send up.

Sources

  1. Hart et al., Geophysical Research Letters (2026), “Growth in Production and Environmental Deposition of Trifluoroacetic Acid Due To Long‐Lived CFC Replacements and Anesthetics”
  2. Lancaster University, press summary with direct quotes from Hart and Hossaini
  3. Environmental Science & Technology review, “The Global Threat from the Irreversible Accumulation of Trifluoroacetic Acid (TFA)” (PMC)